Related Experiment Video

Updated: May 6, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.6K

Transmission of hepatitis C virus: self-limiting hepatitis or chronic hepatitis?

Takafumi Saito1, Yoshiyuki Ueno

  • 1Takafumi Saito, Yoshiyuki Ueno, Department of Gastroenterology, Yamagata University School of Medicine, Yamagata 990-9585, Japan.

World Journal of Gastroenterology
|November 14, 2013
PubMed

Insights

Hepatitis C virus (HCV) transmission involves infectious clones. Host genetics, particularly Interleukin 28B gene variations, influence spontaneous viral clearance and infection outcomes.

Area of Science:

  • Virology
  • Immunogenetics
  • Hepatology

Background:

  • Hepatitis C virus (HCV) exists as diverse quasispecies within an infected host.
  • Most HCV infections lead to chronic hepatitis, but spontaneous clearance occurs in 15-40% of cases.
  • The outcome of acute hepatitis C is influenced by viral factors and host immune responses.

Purpose of the Study:

  • To explore the factors determining spontaneous clearance of hepatitis C virus.
  • To investigate the role of viral evolutionary dynamics in HCV infection.
  • To examine the association between host genetic polymorphisms and HCV susceptibility.

Main Methods:

  • Analysis of HCV quasispecies evolution during transmission.
  • Assessment of host genetic polymorphisms, focusing on the Interleukin 28B gene region.
  • Correlation of genetic factors with spontaneous viral clearance rates.

Main Results:

  • HCV appears to be transmitted as a selected infectious clone.
  • Host genetic variations, especially in the Interleukin 28B gene (encoding interferon-λ-3), are linked to HCV infection susceptibility.
  • These polymorphisms significantly influence the likelihood of spontaneous viral clearance.

Conclusions:

  • Viral and host genetic factors critically determine the outcome of acute hepatitis C infection.
  • Interleukin 28B gene polymorphisms play a key role in modulating the immune response to HCV.
  • Understanding these dynamics is crucial for predicting and managing HCV infection.

Keywords:
Hepatitis CInterferon-λInterleukin 28BSingle nucleotide polymorphismSpontaneous clearance

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

23.7K
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

21.5K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
30
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
49
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
35